Clinical Trial Update: Efficacy and Safety Study of GSK679586 in Patients With Severe Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of GSK679586 in patients with severe asthma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK679586

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2017-12-12